Cleared Traditional

K203097 - HydroMARK Breast Biopsy Site Markers (FDA 510(k) Clearance)

Dec 2020
Decision
63d
Days
Class 2
Risk

K203097 is an FDA 510(k) clearance for the HydroMARK Breast Biopsy Site Markers. This device is classified as a Marker, Radiographic, Implantable (Class II - Special Controls, product code NEU).

Submitted by Devicor Medical Products, Inc. (Cincinnati, US). The FDA issued a Cleared decision on December 16, 2020, 63 days after receiving the submission on October 14, 2020.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4300.

Submission Details

510(k) Number K203097 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 14, 2020
Decision Date December 16, 2020
Days to Decision 63 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NEU — Marker, Radiographic, Implantable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4300